Amoy Diagnostics Co., Ltd. (SHE:300685)
China · Delayed Price · Currency is CNY 17.35
+0.02 (0.12%)
Sep 1, 2026, 3:04 PM CST
Amoy Diagnostics Market Cap
Amoy Diagnostics has a market cap or net worth of 6.68 billion as of August 31, 2026. Its market cap has decreased by -26.66% in one year.
Market Cap
6.68B
Enterprise Value
5.65B
Revenue
1.18B
Ranking
n/a
PE Ratio
20.60
Stock Price
17.35
ChartMarket Cap Chart
Since August 2, 2017, Amoy Diagnostics's market cap has increased from 1.60B to 6.68B, an increase of 318.64%. That is a compound annual growth rate of 17.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 6.68B | -15.54% |
| Dec 31, 2025 | 7.92B | -11.84% |
| Dec 31, 2024 | 8.98B | 3.50% |
| Dec 29, 2023 | 8.67B | -17.63% |
| Dec 30, 2022 | 10.53B | -37.10% |
| Dec 31, 2021 | 16.74B | -3.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 2, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Guangzhou Kingmed Diagnostics Group | 12.70B |
| Dian Diagnostics Group | 11.40B |
| Beijing Strong Biotechnologies,Inc. | 6.86B |
| Shanghai Runda Medical Technology | 5.93B |
| Maccura Biotechnology Co.Ltd | 5.64B |
| Cowealth Medical China | 4.93B |
| Shanghai Labway Clinical Laboratory | 4.45B |
| Guangdong Hybribio Biotech | 3.80B |